Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 2007. Start Trial.
Date Value
July 31, 2026 0.5041
April 30, 2026 0.3001
January 31, 2026 0.2371
October 31, 2025 0.2049
July 31, 2025 0.1795
April 30, 2025 0.5673
January 31, 2025 0.5146
October 31, 2024 0.5026
July 31, 2024 0.49
April 30, 2024 0.3835
January 31, 2024 0.2889
October 31, 2023 0.184
July 31, 2023 0.1823
April 30, 2023 0.1257
January 31, 2023 0.1224
October 31, 2022 0.1083
July 31, 2022 0.017
April 30, 2022 0.0368
January 31, 2022 0.059
October 31, 2021 0.0575
July 31, 2021 0.0593
April 30, 2021 0.0607
January 31, 2021 0.1137
October 31, 2020 0.1373
July 31, 2020 0.2523
Date Value
April 30, 2020 0.2989
January 31, 2020 0.2876
October 31, 2019 0.304
July 31, 2019 0.2943
April 30, 2019 0.162
January 31, 2019 0.1437
October 31, 2018 0.1336
July 31, 2018 0.334
April 30, 2018 0.3006
January 31, 2018 0.00
October 31, 2017 0.00
July 31, 2017 0.00
April 30, 2017 0.00
January 31, 2017 0.0263
June 30, 2016
March 31, 2016
December 31, 2015 0.00
September 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 0.00
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00
December 31, 2013 -0.7627

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Repligen Corp. 0.3271
Bio-Techne Corp. 0.1371
BioLife Solutions, Inc. 0.0375
Maravai Lifesciences Holdings, Inc. 0.8635
MaxCyte, Inc. 0.1087